Investing Profile
Gregory Harriman
InvestorVCAngel
Partner, Chief Investment Officer at BioAdvance
bioadvance.com/team/gregory-h...Pennsylvania
Your Intro Paths to Gregory Harriman
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Networks Gregory is a member of
University of California, Berkeley Network
251 CONNECTIONS
Johnson & Johnson Network
17 CONNECTIONS
Find Gregory Harriman on
cbCurrent Investing Position
BioAdvance Partner
Investment Range
$1.5M - $5.0M
Sweet Spot
$3.3M
Investments On Record
3
Gregory Harriman is on these Sector & Stage Rankings
Gregory Harriman's Investments On Record (2)
| Company | StageDateRound Size | Total Raised |
|---|---|---|
Senzo | SeedDec 2022$2M SeedJul 2022$2M | $4M |
Opsidio | Series UnknownSep 2017$500K | $500K |
Gregory Harriman's Experience
Director Senzo Health2022 - Present
Partner, Chief Investment Officer BioAdvance2021 - Present
Director Opsidio, LLC2017 - Present
Director Treventis2012 - Present
President Main Line Ventures2006 - Present
Director RIBONOVA INC.2016 - 2021
Venture Partner BioAdvance2012 - 2021
Director Genome Profiling, LLC2017 - 2018
Director Enzium, Inc.2015 - 2017
Director Immunome2012 - 2017
Member Robin Hood Ventures2010 - 2017
Director QR Pharma2012 - 2014
Research Professor, School of Biomedical Engineering, Science and Health Systems Drexel University2010 - 2014
Director Novira Therapeutics2011 - 2012
Vice President Johnson & Johnson2001 - 2009
Executive Director Centocor1998 - 2001
Medical Director IVAX1996 - 1998
Assistant Professor of Medicine Baylor College of Medicine1991 - 1996
Gregory Harriman's Education
UC San Diego School of Medicine M.D. Medicine
University of California, Berkeley
Founders who looked at Gregory Harriman's profile also looked at these Investors